CorMedix Inc. 4
4 · CorMedix Inc. · Filed Apr 1, 2010
Insider Transaction Report
Form 4
CorMedix Inc.CRMD
Houser Mark T.
Chief Medical Officer
Transactions
- Conversion
12% Convertible Notes
2010-03-30−14,652→ 0 total→ Units consisting of common stoc (14,652 underlying) - Conversion
Common Stock, $0.001 par value per share
2010-03-30+29,304→ 42,832 total - Award
Stock option (right to buy)
2010-03-30+326,492→ 326,492 totalExercise: $3.13Exp: 2020-03-30→ Common Stock, $0.001 par value per share (326,492 underlying) - Conversion
Warrants issued as a part of Units
2010-03-30+14,652→ 14,652 totalExercise: $3.44Exp: 2015-03-24→ Common Stock, $0.001 par value per share (14,652 underlying)
Footnotes (3)
- [F1]The 12% Convertible Notes, and all accrued interest thereon, automatically converted into Units upon the consummation of the Company's initial public offering at a conversion price of $6.50 per Unit, the initial public offering price. Each Unit consists of two shares of common stock and a warrant to purchase one share of common stock at an exercise price of $3.4375 per share. Each warrant will become exercisable upon the earlier to occur of the expiration of the underwriters' over allotment option or its exercise in full (in connection with the Company's initial public offering), and will expire on March 24, 2015, or earlier upon redemption.
- [F2]Each Unit consists of two shares of common stock and a warrant to purchase one share of common stock at an exercise price of $3.4375 per share. Each warrant will become exercisable upon the earlier to occur of the expiration of the underwriters' over allotment option or its exercise in full (in connection with the Company's initial public offering), and will expire on March 24, 2015, or earlier upon redemption.
- [F3]These options vest as follows: 1/3 on March 30, 2011; an additional 1/3 on March 30, 2012; and the remaining 1/3 on March 30, 2013.